Arun K Sharma Selected Research

ASR352

1/2019

ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arun K Sharma Research Topics

Disease

59	Neoplasms (Cancer) 04/2024 - 07/2002
17	Breast Neoplasms (Breast Cancer) 01/2023 - 07/2002
14	Melanoma (Melanoma, Malignant) 01/2023 - 08/2006
9	Carcinogenesis 03/2024 - 07/2002
8	Inflammation (Inflammations) 06/2023 - 11/2014
8	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 03/2016
7	Myocardial Infarction 03/2024 - 08/2018
7	Colonic Neoplasms (Colon Cancer) 08/2023 - 04/2010
6	Necrosis 06/2023 - 11/2018
5	Neoplasm Metastasis (Metastasis) 02/2024 - 08/2006
4	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 02/2013
4	Lung Neoplasms (Lung Cancer) 11/2020 - 12/2008
3	Obesity 03/2024 - 01/2008
3	Tuberculosis (Tuberculoses) 01/2023 - 10/2019
3	Ischemia 03/2022 - 11/2018
3	Ulcerative Colitis 01/2022 - 01/2021
3	Adenocarcinoma 05/2021 - 07/2002
2	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 09/2022
2	Wounds and Injuries (Trauma) 06/2023 - 01/2023
2	Infections 01/2023 - 01/2023
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 11/2020
2	Multiple Myeloma 01/2023 - 10/2014
2	Cataract (Cataracts) 11/2022 - 01/2020
2	Hyperglycemia 08/2022 - 02/2019
2	Dyslipidemias (Dyslipidemia) 08/2022 - 05/2021
2	Fibrosis (Cirrhosis) 05/2022 - 01/2006
2	Diabetes Mellitus 03/2022 - 02/2016
2	Leishmaniasis 01/2022 - 01/2019
2	Heart Failure 11/2021 - 01/2020
2	Insulin Resistance 09/2021 - 12/2007
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2021 - 01/2008
2	Type 2 Diabetes Mellitus (MODY) 05/2021 - 02/2019
2	Celiac Disease (Celiac Sprue) 02/2021 - 08/2008
2	Hepatomegaly 01/2021 - 01/2021
2	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2021 - 12/2020
2	Drug-Related Side Effects and Adverse Reactions 01/2020 - 02/2019
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 12/2018 - 01/2016
2	Carcinoma (Carcinomatosis) 05/2016 - 12/2006

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 03/2024 - 08/2006
10	SeleniumIBA 01/2023 - 03/2009
6	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 04/2010
6	dibenzo(a,l)pyreneIBA 07/2014 - 12/2006
5	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 07/2002
5	PPAR-betaIBA 07/2010 - 12/2007
5	LigandsIBA 07/2010 - 12/2007
4	AntioxidantsIBA 08/2023 - 08/2018
4	CytokinesIBA 06/2023 - 10/2013
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023 - 03/2016
4	SulfurIBA 01/2019 - 03/2009
4	IsothiocyanatesIBA 01/2019 - 03/2009
4	ISC-4 compoundIBA 01/2018 - 07/2011
4	Tamoxifen FDA LinkGeneric 04/2016 - 10/2007
4	Environmental Pollutants (Pollutants, Environmental)IBA 07/2014 - 08/2004
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2010 - 12/2007
3	MicroRNAs (MicroRNA)IBA 03/2024 - 04/2010
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2023 - 11/2021
3	Caspase 3 (Caspase-3)IBA 08/2023 - 05/2021
3	CaspasesIBA 06/2023 - 01/2013
3	EnzymesIBA 01/2023 - 01/2004
3	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 01/2018
3	LipidsIBA 08/2022 - 09/2010
3	CopperIBA 03/2022 - 08/2018
3	Phosphotransferases (Kinase)IBA 03/2021 - 08/2006
3	thiobarbituric acidIBA 03/2021 - 01/2018
3	Testosterone (Sustanon)FDA Link 01/2021 - 11/2016
3	sphingosine kinaseIBA 07/2017 - 09/2010
3	CarcinogensIBA 01/2016 - 07/2002
3	SmokeIBA 01/2016 - 09/2013
3	DNA AdductsIBA 07/2014 - 12/2006
3	(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA 09/2010 - 12/2007
2	PlatinumIBA 01/2024 - 09/2017
2	VaccinesIBA 07/2023 - 02/2021
2	CarbonIBA 01/2023 - 03/2009
2	Annexin A5IBA 09/2022 - 10/2012
2	selenocyanic acid (selenocyanate)IBA 09/2022 - 10/2011
2	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 09/2021
2	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2021 - 01/2018
2	Gemcitabine FDA Link 05/2021 - 11/2020
2	Insulin (Novolin)FDA Link 05/2021 - 02/2019
2	Estrogens (Estrogen)FDA Link 01/2021 - 12/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2016
2	GW 7647IBA 01/2021 - 01/2021
2	Carrier Proteins (Binding Protein)IBA 07/2020 - 07/2011
2	Messenger RNA (mRNA)IBA 07/2020 - 04/2010
2	Urea (Carbamide)FDA LinkGeneric 01/2019 - 05/2016
2	NISC-6IBA 01/2019 - 07/2017
2	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 01/2013
2	isoselenocyanateIBA 01/2019 - 07/2017
2	isothiocyanic acidIBA 01/2018 - 08/2011
2	Small Interfering RNA (siRNA)IBA 01/2018 - 08/2006
2	selenoureaIBA 07/2017 - 05/2016
2	NaphthalimidesIBA 07/2017 - 08/2011
2	ThioureaIBA 05/2016 - 08/2011
2	Selective Estrogen Receptor Modulators (SERM)IBA 04/2016 - 03/2009

Therapy/Procedure

20	Therapeutics 04/2024 - 10/2007
4	Drug Therapy (Chemotherapy) 02/2024 - 04/2012
3	Oral Administration 01/2023 - 07/2002
2	Quantum Dots (Quantum Dot) 06/2023 - 01/2023
2	Phacoemulsification 11/2022 - 01/2020